0001493152-15-006455.txt : 20151229
0001493152-15-006455.hdr.sgml : 20151229
20151229172506
ACCESSION NUMBER: 0001493152-15-006455
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151202
FILED AS OF DATE: 20151229
DATE AS OF CHANGE: 20151229
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akers Biosciences Inc
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: 201 GROVE RD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 201 GROVE RD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gormally John J
CENTRAL INDEX KEY: 0001661118
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36268
FILM NUMBER: 151311884
MAIL ADDRESS:
STREET 1: 80 WALSH DRIVE
CITY: MAHWAH
STATE: NJ
ZIP: 07430
3
1
form3.xml
X0206
3
2015-12-02
1
0001321834
Akers Biosciences Inc
AKER
0001661118
Gormally John J
80 WALSH DRIVE
MAHWAH
NJ
07430
0
1
0
0
Chief Executive Officer
Akers Biosciences, Inc. (the "Company") approved the appointment John J. Gormally as Chief Executive Officer of the Company, subject to the terms of conditions of an executed employment agreement. On December 2, 2015, the Company and Mr. Gormally finalized the terms of his employment and entered into an employment agreement (the "Employment Agreement"), pursuant to which Mr. Gormally will serve as the Company's Chief Executive Officer.
/s/ John J. Gormally
2015-12-29